FI970202A0 - Kovaa kudosta stimuloiva aine - Google Patents

Kovaa kudosta stimuloiva aine

Info

Publication number
FI970202A0
FI970202A0 FI970202A FI970202A FI970202A0 FI 970202 A0 FI970202 A0 FI 970202A0 FI 970202 A FI970202 A FI 970202A FI 970202 A FI970202 A FI 970202A FI 970202 A0 FI970202 A0 FI 970202A0
Authority
FI
Finland
Prior art keywords
pct
hard tissue
sec
date
regeneration
Prior art date
Application number
FI970202A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970202A (fi
Inventor
Hans-Arne Hansson
Gunilla Johansson-Ruden
Olle Larm
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI970202A publication Critical patent/FI970202A/fi
Publication of FI970202A0 publication Critical patent/FI970202A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI970202A 1994-07-19 1997-01-17 Kovaa kudosta stimuloiva aine FI970202A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402528A SE9402528D0 (sv) 1994-07-19 1994-07-19 Hårdvävnadsstimulerande med el
PCT/SE1995/000857 WO1996002259A1 (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent

Publications (2)

Publication Number Publication Date
FI970202A FI970202A (fi) 1997-01-17
FI970202A0 true FI970202A0 (fi) 1997-01-17

Family

ID=20394768

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970202A FI970202A0 (fi) 1994-07-19 1997-01-17 Kovaa kudosta stimuloiva aine

Country Status (22)

Country Link
US (1) US5894070A (pl)
EP (1) EP0771206B1 (pl)
JP (1) JP3492377B2 (pl)
KR (1) KR100395724B1 (pl)
CN (1) CN1081923C (pl)
AT (1) ATE219678T1 (pl)
BR (1) BR9508322A (pl)
CA (1) CA2194462C (pl)
CZ (1) CZ289981B6 (pl)
DE (1) DE69527203T2 (pl)
DK (1) DK0771206T3 (pl)
ES (1) ES2178675T3 (pl)
FI (1) FI970202A0 (pl)
HU (1) HU220770B1 (pl)
IS (1) IS1793B (pl)
MX (1) MX9700443A (pl)
NO (1) NO310223B1 (pl)
NZ (1) NZ290219A (pl)
PL (1) PL181764B1 (pl)
RU (1) RU2153877C2 (pl)
SE (1) SE9402528D0 (pl)
WO (1) WO1996002259A1 (pl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402528D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Hårdvävnadsstimulerande med el
KR100237738B1 (ko) * 1997-04-26 2000-01-15 이용찬 생채 매식용 의료기구 임플란트의 기능 향상방법
DE19724869C2 (de) * 1997-06-12 1999-05-12 Henkel Kgaa Verwendung von Citosanderivaten zur Oberflächenbeschichtung
US5993535A (en) * 1997-08-28 1999-11-30 Ngk Spark Plug Co., Ltd. Calcium phosphate cement and calcium phosphate cement composition
JP4215884B2 (ja) * 1998-03-23 2009-01-28 日本特殊陶業株式会社 リン酸カルシウムセメント及びリン酸カルシウムセメント組成物
US6372257B1 (en) 1999-06-29 2002-04-16 J. Alexander Marchosky Compositions and methods for forming and strengthening bone
US20030147860A1 (en) 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
CA2335058A1 (en) 1998-06-22 1999-12-29 Danforth Joslyn Method, implant and delivery system for enhancing blood flow in tissue
JP4606586B2 (ja) * 1998-11-10 2011-01-05 株式会社ネーテック 機能性キトサン誘導体
FR2791262B1 (fr) * 1999-03-22 2001-09-28 Virbac Sa Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
FI19991852A (fi) 1999-09-01 2001-03-01 Yli Urpo Antti Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
CA2685349C (en) * 1999-11-15 2013-09-17 Bio Syntech Canada Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
WO2001041821A1 (en) * 1999-12-09 2001-06-14 Biosyntech Canada Inc. Mineral-polymer hybrid composition
EP1294414B1 (en) * 2000-06-29 2006-03-15 Biosyntech Canada Inc. Composition and method for the repair and regeneration of cartilage and other tissues
ES2169681B1 (es) * 2000-08-10 2003-10-01 Osfarma S L Metodo de produccion de filmes de quitosan con una alta capacidad de adherencia celular, producto obrenido y aplicaciones.
CA2429168C (en) * 2000-11-15 2010-06-08 Bio Syntech Canada Inc. Method for restoring a damaged or degenerated intervertebral disc
JP5614913B2 (ja) * 2002-07-16 2014-10-29 ピラマル ヘルスケア （カナダ） リミテッド 生細胞又は生物学的活性因子を封入し送達するための、細胞適合性、注射可能、かつ自己ゲル化性のキトサン溶液の組成物
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
FR2844717B1 (fr) * 2002-09-23 2006-07-07 Richard Cancel Plaque de renfort comprenant notamment du chitosane
CN100394989C (zh) * 2002-11-15 2008-06-18 华沙整形外科股份有限公司 包含微粒状基于胶原材料的组合物的制药应用和包含所述组合物的滑膜关节
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
DE10338110A1 (de) * 2003-08-15 2005-03-10 Biomet Deutschland Gmbh Mit Chitosan beschichteter metallischer Gegenstand sowie Verfahren zu dessen Herstellung
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
US8734525B2 (en) * 2003-12-31 2014-05-27 Warsaw Orthopedic, Inc. Osteoinductive demineralized cancellous bone
US8328876B2 (en) * 2003-12-31 2012-12-11 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
FR2866571B1 (fr) * 2004-02-20 2007-09-21 Philippe Zanchetta Utilisation d'un melange de polysaccharides specifiques denomme par l'inventeur ezbone, comprenant de l'acide hyaluronique, de la chondroitine 6 sulfate, du dermatane sulfate et de l'heparine en cicatrisation osseuse.
AU2005239977B2 (en) * 2004-05-07 2010-11-11 The University Of Queensland Composition for stimulating bone growth and differentiation and method for isolating same
EP1744766A4 (en) * 2004-05-07 2008-08-20 Univ Queensland COMPOSITION FOR STIMULATING BONE GROWTH AND DIFFERENTIATION AND CORRESPONDING METHOD
ES2527293T3 (es) 2004-08-16 2015-01-22 Cellresearch Corporation Pte Ltd Aislamiento de células madre/progenitoras de membrana amniótica del cordón umbilical
US20080118542A1 (en) * 2005-01-19 2008-05-22 Bonoss Medical Ab Growth Factor Composition
WO2007046775A1 (en) 2005-10-21 2007-04-26 Cellresearch Corporation Pte Ltd Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
US8911759B2 (en) * 2005-11-01 2014-12-16 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
EP1945712A4 (en) * 2005-11-04 2013-05-01 Piramal Healthcare Canada Ltd BINDING OF AQUEOUS POLYELECTROLYTE SOLUTIONS BY THERMALLY INDUCED CHANGES IN THE IONIZATION CONDITION
DE102006020035A1 (de) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
US8399619B2 (en) * 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
EP1977739A1 (en) * 2007-04-03 2008-10-08 Bioiberica, S.A. Nanoparticulate composition of chitosan and chondroitin sulfate
WO2008157497A2 (en) * 2007-06-15 2008-12-24 Osteotech, Inc. Method of treating tissue
AU2008265850B2 (en) * 2007-06-15 2014-06-26 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
WO2009009688A1 (en) * 2007-07-10 2009-01-15 Osteotech, Inc. Delivery system
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
ES2446544T3 (es) * 2007-10-19 2014-03-10 Warsaw Orthopedic, Inc. Composiciones de matrices óseas desmineralizadas y métodos
GB2463474B (en) 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
WO2010093955A1 (en) * 2009-02-12 2010-08-19 Osteotech,Inc. Segmented delivery system
MX2014008404A (es) 2012-01-27 2014-08-22 Hoffmann La Roche Quitosan enlazado covalentamente con antagonista de la integrina de molecula pequeña para suministro dirigido.
EP3003026B1 (en) 2013-03-14 2019-07-17 Tricol Biomedical, Inc. Biocompatible and bioabsorbable derivatized chitosan compositions
CN105126165B (zh) * 2015-01-21 2017-12-08 中国人民解放军第三〇七医院 一种钛牙种植体材料及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL163522B (nl) * 1970-07-20 1980-04-15 Montedison Spa Werkwijze om een katalysator te bereiden voor de polymerisatie van alkenen-1.
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5256447A (en) * 1991-12-31 1993-10-26 Minnesota Mining And Manufacturing Company Adhesive composition and method
AU3233493A (en) * 1991-12-31 1993-07-28 Minnesota Mining And Manufacturing Company Metal filled adhesive composition and method
SE9402528D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Hårdvävnadsstimulerande med el

Also Published As

Publication number Publication date
PL181764B1 (pl) 2001-09-28
CA2194462A1 (en) 1996-02-01
ATE219678T1 (de) 2002-07-15
ES2178675T3 (es) 2003-01-01
HU220770B1 (hu) 2002-05-28
DE69527203D1 (de) 2002-08-01
NO970215L (no) 1997-01-17
IS1793B (is) 2001-12-12
CA2194462C (en) 2007-07-10
FI970202A (fi) 1997-01-17
IS4409A (is) 1997-01-06
EP0771206A1 (en) 1997-05-07
EP0771206B1 (en) 2002-06-26
KR100395724B1 (ko) 2004-02-18
CZ289981B6 (cs) 2002-05-15
NO310223B1 (no) 2001-06-11
AU696183B2 (en) 1998-09-03
HU9700160D0 (en) 1997-03-28
BR9508322A (pt) 1998-01-06
JPH10502664A (ja) 1998-03-10
CZ14097A3 (en) 1997-07-16
MX9700443A (es) 1997-04-30
US5894070A (en) 1999-04-13
WO1996002259A1 (en) 1996-02-01
RU2153877C2 (ru) 2000-08-10
AU3089595A (en) 1996-02-16
KR970704459A (ko) 1997-09-06
CN1157568A (zh) 1997-08-20
JP3492377B2 (ja) 2004-02-03
PL318326A1 (en) 1997-06-09
DE69527203T2 (de) 2003-01-09
SE9402528D0 (sv) 1994-07-19
NO970215D0 (no) 1997-01-17
NZ290219A (en) 1998-06-26
DK0771206T3 (da) 2002-08-19
HUT77607A (hu) 1998-06-29
CN1081923C (zh) 2002-04-03

Similar Documents

Publication Publication Date Title
FI970202A0 (fi) Kovaa kudosta stimuloiva aine
NO303425B1 (no) FremgangsmÕte for behandling av et kirurgisk metallimplantat
RU97102352A (ru) Агент, стимулирующий твердую ткань
DE69918717D1 (de) Knochentransplantat aus knochenpartikel
EP2071020A3 (en) Tissue Implant
SE9003206D0 (sv) Saett foer ytbehandling av implantat av titan eller titanlegering
SE9404196D0 (sv) New antithrombotic formulation
ES2180649T3 (es) Agente antiadherente.
ATE492304T1 (de) Verwendung von dreidimensionalen prothesen, die hyaluronsäurederivate enthalten
ES2041977T3 (es) Impplante percutaneo.
FR2811229B1 (fr) Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus en cicatrisation osseuse
EP2202241A3 (en) Therapeutic compounds and methods for modulating V3, a versican isoform
BG102375A (en) Inoculation biocompatible hydrophilic gel, method for its preparation and application
RU2000103476A (ru) Способ лечения больных с нарушениями консолидации переломов длинных костей конечностей